1. Home
  2. BLCO vs ACA Comparison

BLCO vs ACA Comparison

Compare BLCO & ACA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • ACA
  • Stock Information
  • Founded
  • BLCO 1853
  • ACA 2018
  • Country
  • BLCO Canada
  • ACA United States
  • Employees
  • BLCO N/A
  • ACA N/A
  • Industry
  • BLCO Ophthalmic Goods
  • ACA Metal Fabrications
  • Sector
  • BLCO Health Care
  • ACA Industrials
  • Exchange
  • BLCO Nasdaq
  • ACA Nasdaq
  • Market Cap
  • BLCO 4.9B
  • ACA 4.2B
  • IPO Year
  • BLCO 2022
  • ACA N/A
  • Fundamental
  • Price
  • BLCO $14.66
  • ACA $88.04
  • Analyst Decision
  • BLCO Hold
  • ACA Buy
  • Analyst Count
  • BLCO 12
  • ACA 3
  • Target Price
  • BLCO $15.55
  • ACA $104.00
  • AVG Volume (30 Days)
  • BLCO 865.0K
  • ACA 264.8K
  • Earning Date
  • BLCO 07-30-2025
  • ACA 08-04-2025
  • Dividend Yield
  • BLCO N/A
  • ACA 0.23%
  • EPS Growth
  • BLCO N/A
  • ACA N/A
  • EPS
  • BLCO N/A
  • ACA 1.59
  • Revenue
  • BLCO $4,829,000,000.00
  • ACA $2,603,300,000.00
  • Revenue This Year
  • BLCO $6.99
  • ACA $13.51
  • Revenue Next Year
  • BLCO $5.46
  • ACA $6.07
  • P/E Ratio
  • BLCO N/A
  • ACA $55.78
  • Revenue Growth
  • BLCO 11.94
  • ACA 10.44
  • 52 Week Low
  • BLCO $10.45
  • ACA $68.11
  • 52 Week High
  • BLCO $21.69
  • ACA $113.43
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 68.51
  • ACA 47.32
  • Support Level
  • BLCO $13.81
  • ACA $87.41
  • Resistance Level
  • BLCO $14.49
  • ACA $91.38
  • Average True Range (ATR)
  • BLCO 0.42
  • ACA 1.87
  • MACD
  • BLCO 0.00
  • ACA -0.19
  • Stochastic Oscillator
  • BLCO 76.70
  • ACA 32.82

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About ACA Arcosa Inc.

Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.

Share on Social Networks: